MOTTA STEFANO

Rivara, M., Malacrida, A., Ghizzi, M., Bentivegna, A., Sica, F., Re, F., et al. (2026). Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment. BIOLOGY, 15(16) [10.3390/biology15161371]. Dettaglio

Frigerio, G., Donadoni, E., Siani, P., Vertemara, J., Motta, S., Bonati, L., et al. (2025). Mechanism of Ligand-Activated Nanoparticles Binding to Target Cell-Surface Receptors by All-Atom Molecular Dynamics. Intervento presentato a: 2025 MRS Spring Meeting, Seattle, USA. Dettaglio

Motta, S., Callea, L., Mulla, S., Davoudkhani, H., Bonati, L., Pandini, A. (2025). SOMMD: an R package for the analysis of molecular dynamics simulations using self-organizing map. BIOINFORMATICS, 41(6) [10.1093/bioinformatics/btaf308]. Dettaglio

Frigerio, G., Motta, S., Siani, P., Donadoni, E., Di Valentin, C. (2025). Unveiling the drug delivery mechanism of graphene oxide dots at the atomic scale. JOURNAL OF CONTROLLED RELEASE, 379(10 March 2025), 344-362 [10.1016/j.jconrel.2025.01.020]. Dettaglio

Frigerio, G., Donadoni, E., Siani, P., Vertemara, J., Motta, S., Bonati, L., et al. (2024). Mechanism of a nanodevice binding to its target protein by atomistic molecular dynamics: the case of RGD-conjugated PEGylated TiO2 nanoparticles binding to integrins αVβ3. Intervento presentato a: Research and Nanomedicine - June 13, 2024, Pavia, Italia. Dettaglio